Results 31 to 40 of about 239,135 (329)

Tralokinumab plus topical corticosteroids for the treatment of moderate‐to‐severe atopic dermatitis: results from the double‐blind, randomized, multicentre, placebo‐controlled phase III ECZTRA 3 trial*

British Journal of Dermatology, 2020
Tralokinumab is a fully human monoclonal antibody that specifically neutralizes interleukin‐13, a key driver of atopic dermatitis (AD).
J. Silverberg, D. Toth, T. Bieber, Andrew F. Alexis, B. Elewski, A. Pink, D. Hijnen, T. N. Jensen, B. Bang, C. Olsen, A. Kurbasic, S. Weidinger   +11 more
semanticscholar   +1 more source

Malassezia pachydermatis Carriage in Dog Owners

Emerging Infectious Diseases, 2005
Yeasts of the genus Malassezia serve as both commensal microorganisms and pathogens on the skin of humans and domestic animals. Although rare, cases of life-threatening fungemia in people have been attributed to Malassezia pachydermatis, for which dogs ...
Daniel O. Morris, Kathleen O’Shea, Frances S. Shofer, Shelley Rankin   +3 more
doaj   +1 more source

Unraveling the skin; a comprehensive review of atopic dermatitis, current understanding, and approaches

Frontiers in Immunology
Atopic dermatitis, also known as atopic eczema, is a chronic inflammatory skin disease characterized by red pruritic skin lesions, xerosis, ichthyosis, and skin pain.
Moeina Afshari, M. Kolácková, Michaela Rosecka, J. Čelakovská, J. Krejsek   +4 more
semanticscholar   +1 more source

Epidemiology of atopic dermatitis in adults: Results from an international survey

Allergy. European Journal of Allergy and Clinical Immunology, 2018
There are gaps in our knowledge of the prevalence of adult atopic dermatitis (AD).
S. Barbarot, S. Auzière, A. Gadkari, G. Girolomoni, L. Puig, E. Simpson, D. Margolis, M. Bruin-Weller, L. Eckert   +8 more
semanticscholar   +1 more source

Trial of Nemolizumab and Topical Agents for Atopic Dermatitis with Pruritus.

New England Journal of Medicine, 2020
BACKGROUND Nemolizumab is a subcutaneously administered humanized monoclonal antibody against interleukin-31 receptor A, which is involved in pruritus and inflammation in atopic dermatitis.
K. Kabashima, T. Matsumura, Hiroshi Komazaki, M. Kawashima   +3 more
semanticscholar   +1 more source

Efficacy and Safety of Abrocitinib in Combination With Topical Therapy in Adolescents With Moderate-to-Severe Atopic Dermatitis

JAMA dermatology, 2021
Key Points Question What is the short-term efficacy and safety of oral abrocitinib in adolescents with moderate-to-severe atopic dermatitis? Findings In the randomized clinical trial JADE TEEN, a phase 3 study of abrocitinib in combination with topical ...
L. Eichenfield, C. Flohr, R. Sidbury, E. Siegfried, Z. Szalai, R. Galus, Z. Yao, Hidetoshi Takahashi, S. Barbarot, C. Feeney, Fan Zhang, M. Dibonaventura, R. Rojo, H. Valdez, G. Chan   +14 more
semanticscholar   +1 more source

Assessment of the quality of life of pediatric patients with the major chronic childhood skin diseases Avaliação da qualidade de vida em pacientes pediátricos com as principais dermatoses crônicas da infância

Anais Brasileiros de Dermatologia, 2012
BACKGROUND: The skin is the primary interface of the human being with the external environment and the presence of skin diseases can have substantial effects on the quality of life.
Ana Paula Dornelles da Silva Manzoni, Rita Langie Pereira, Roberta Zaffari Townsend, Magda Blessmann Weber, Aline Rodrigues da Silva Nagatomi, Tania Ferreira Cestari   +5 more
doaj   +1 more source

The Quality of Life of Allergic Cats, Treated with Allergen-Specific Immunotherapy – A Retrospective Study

Acta Veterinaria, 2023
Feline atopic skin syndrome (FASS) describes allergic skin diseases in cats associated with sensitivity to environmental allergens. Allergen-specific immunotherapy (ASIT) aims to reduce or eliminate symptoms associated with subsequent exposure to the ...
Kotnik Tina, Leder Matic
doaj   +1 more source

Nationwide Survey of Atopic Myelitis and Plexin D1‐Immunoglobulin G‐Related Pain

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To elucidate the features of plexin D1‐immunoglobulin (Ig)G‐associated neuropathic pain and its relationship to atopic myelitis (AM) in a nationwide Japanese survey. Methods A preliminary survey questionnaire was sent to 1574 selected departments (neurology and pediatrics/pediatric neurology) to explore the numbers of AM and plexin ...
Jun‐ichi Kira, Xu Zhang, Takayuki Fujii, Mikio Mitsuishi, Miho Ushijima, Sato Yoshidomi, Ayako Sakoda, Tomohiro Imamura, Satoshi Kuwabara, Noriko Isobe, Yuri Nakamura   +10 more
wiley   +1 more source

JAK 1-3 inhibitors and TYK-2 inhibitors in dermatology: Practical pearls for the primary care physician

Journal of Family Medicine and Primary Care
Guidelines for primary care clinicians on monitoring and safety guidelines regarding Janus kinase and tyrosine kinase 2 inhibitors in the treatment of inflammatory skin conditions are often unclear.
Abigail Beard, Shannon C. Trotter
doaj   +1 more source